Technical Analysis for VRX - Valeant Pharmaceuticals International, Inc.

Grade Last Price % Change Price Change
grade B 22.07 -0.32% -0.07
VRX closed down 0.32 percent on Monday, May 21, 2018, on 57 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical VRX trend table...

Date Alert Name Type % Chg
May 21 Outside Day Range Expansion 0.00%
May 21 Wide Bands Range Expansion 0.00%
May 21 Overbought Stochastic Strength 0.00%
May 18 Spinning Top Other -0.32%
May 18 Narrow Range Bar Range Contraction -0.32%
May 18 NR7 Range Contraction -0.32%
May 18 NR7-2 Range Contraction -0.32%
May 18 Inside Day Range Contraction -0.32%
May 18 Wide Bands Range Expansion -0.32%
May 18 Overbought Stochastic Strength -0.32%

Older signals for VRX ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Valeant Pharmaceuticals International, Inc., a specialty pharmaceutical company, develops, manufactures, and markets pharmaceutical products and medical devices in the areas of neurology, dermatology, and branded generics. It offers dermatology products, such as Zovirax Ointment, Xerese, Retin-A Micro, Elidel, Carac, Acanya gel, Sculptra and Sculptra Aesthetic, Atralin, Solodyn, Zyclara, Ziana, Vanos, Restylane family of products, and Dysport; over-the-counter (OTC) products, including CeraVe and AcneFree; dentistry products, such as Arestin and Teeth Whitening System; ophthalmology products, including Timoptic, Timoptic, Macugen, and Visudyne; and neurology and other products, such as Wellbutrin XL and Xenazine in the United States. The company also provides pharmaceutical products, including Tiazac XC, Wellbutrin XL, Zovirax, Benzaclin, and Penlac; and Cold-FX, an OTC product in Canada, as well as Duromine/Metermine, Difflam, Duro-Tuss, and Rikodeine in Australia. In addition, it offers a range of treatments, including antibiotics, treatments for cardiovascular and neurological diseases, dermatological products, and diabetic therapies, as well as a range of various OTC products in Europe; and products for a range of therapeutic classes, including vitamin deficiency, antibacterials, and dermatology in Mexico and Brazil. Further, the company provides Duromine, Andolex, and Pholtex products in South Africa; and Difflam, Duro-Tuss, Tambocor, and Norgesic in Asia. The company was formerly known as Biovail Corporation and changed its name to Valeant Pharmaceuticals International, Inc. in September 2010. Valeant Pharmaceuticals International, Inc. was founded in 1983 and is headquartered in Laval, Canada.
Is VRX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 24.43
52 Week Low 10.94
Average Volume 8,262,652
200-Day Moving Average 16.7538
50-Day Moving Average 17.5772
20-Day Moving Average 19.537
10-Day Moving Average 21.157
Average True Range 0.7675
ADX 43.63
+DI 38.7
-DI 7.35
Chandelier Exit (Long, 3 ATRs ) 20.2875
Chandelier Exit (Short, 3 ATRs ) 19.2825
Upper Bollinger Band 23.0302
Lower Bollinger Band 16.0438
Percent B (%b) 0.86
BandWidth 35.75984
MACD Line 1.3373
MACD Signal Line 1.0726
MACD Histogram 0.2647
Fundamentals Value
Market Cap 7.7 Billion
Num Shares 349 Million
EPS -3.27
Price-to-Earnings (P/E) Ratio -6.75
Price-to-Sales 0.44
Price-to-Book 1.03
PEG Ratio -0.33
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 23.05
Resistance 3 (R3) 23.11 22.85 22.88
Resistance 2 (R2) 22.85 22.60 22.82 22.83
Resistance 1 (R1) 22.46 22.45 22.33 22.40 22.77
Pivot Point 22.20 22.20 22.14 22.17 22.20
Support 1 (S1) 21.81 21.95 21.68 21.75 21.37
Support 2 (S2) 21.55 21.80 21.52 21.31
Support 3 (S3) 21.16 21.55 21.26
Support 4 (S4) 21.10